OncoTherapy Science, Inc. (TYO:4564)
Japan flag Japan · Delayed Price · Currency is JPY
15.00
0.00 (0.00%)
Nov 18, 2026, 10:39 AM JST

OncoTherapy Science Balance Sheet

Millions JPY. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
2,0832,0898335271,1171,836
Cash & Short-Term Investments
2,0832,0898335271,1171,836
Cash Growth
24.36%150.78%58.06%-52.82%-39.16%-36.67%
Accounts Receivable
821039835123399
Other Receivables
---153--
Receivables
8210398188123399
Inventory
8462787399231
Other Current Assets
4055962983134
Total Current Assets
2,2892,3091,1058171,4222,600
Long-Term Investments
494949498984
Other Long-Term Assets
-111-1
Total Assets
2,3382,3591,1558671,5112,685

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Current Income Taxes Payable
214142163141318558
Other Current Liabilities
142716421829146
Total Current Liabilities
228169327359609604
Other Long-Term Liabilities
484910015548102
Total Liabilities
276218427514657706

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
298505050789789
Additional Paid-In Capital
30,08729,83927,51626,32224,79324,793
Retained Earnings
-28,393-27,818-26,908-26,092-24,804-23,686
Comprehensive Income & Other
707070737683
Total Common Equity
2,0622,1417283538541,979
Shareholders' Equity
2,0622,1417283538541,979
Total Liabilities & Equity
2,3382,3591,1558671,5112,685

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Cash (Debt)
2,0832,0898335271,1171,836
Net Cash Growth
24.36%150.78%58.06%-52.82%-39.16%-36.67%
Net Cash Per Share
5.446.363.192.485.809.79
Filing Date Shares Outstanding
408.3398.64277.64239.34206.64192.64
Total Common Shares Outstanding
408.3383.64271.64217.64192.64192.64
Working Capital
2,0612,1407784588131,996
Book Value Per Share
5.055.582.681.624.4310.27
Tangible Book Value
2,0622,1417283538541,979
Tangible Book Value Per Share
5.055.582.681.624.4310.27